Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human... see more

TSXV:CZO - Post Discussion

Ceapro Inc > Germany
View:
Post by archeo753 on Apr 30, 2021 11:24am

Germany

Looks like 2 years before any revenue from German operations.  From page 7.

In 2020, Ceapro bought equipment from a larger scale supercritical plant in Germany and engaged a manufacturer for the modification and conversion of the retained equipment to comply with PGX unique requirements. The new PGX installation will be designed for an initial capacity of 20 metric tons per year mostly for the production of yeast beta glucan to be sold as a nutraceutical (immunomodulating) product.The design and manufacturing of modular PGX equipment should take between six to nine months while the instal-lation of the PGX plant, utilities, facilities upgrades and commissioning of the production facility should take an ad-ditional nine to twelve months. The final decision on location is pending upon receipt of invitational packages from different cities. While this project is taking shape in Europe, considerable amount of work has been completed for the installation of a commercial scale impregnation unit at the Edmonton based facility for the production of new chemical complexes. It is anticipated that commissioning of this impregnation system will be completed during the second half of 2021. Commercial scale up level is critical for out-licensing applications produced using the PGX Technology.
Comment by Ciao on Apr 30, 2021 11:42am
If commissioned by H2 2021, potential for rev. in H2 2021 or Q1 2022. Why would you say 2 years?
Comment by Ciao on Apr 30, 2021 11:45am
You're right, I was commenting on Edmonton site.
Comment by prophetoffacts on Apr 30, 2021 1:44pm
This post has been removed in accordance with Community Policy
Comment by Ciao on Apr 30, 2021 5:27pm
Now we also know why the city to which the plant is to be located was not given as it still isn't known.  So where is the equipment now? It was to be taken apart and put on skids, placed somewhere, re-assembled and tweaked to PGX specifications? Then disassembled put back on skids til a plant in a city is secured? 
Comment by Ciao on Apr 30, 2021 7:26pm
My reading comprehension was poor, the equipment is being tweaked at a vendor's location.
Comment by EbbFlow88 on Apr 30, 2021 1:44pm
It would seem that a NCC deal should be struck in H1 2021 and we'd be ready for production in H2/Q1 2022. That would be a nice bump in sales and earnings as well as cash holdings.  I wonder the capacity and how many deals/ products they could make out of Edmonton. Then that should lead into the German plant in ~2 years with further bump in sales and output. Tack on the Cholesterol pill ...more  
Comment by Ciao on Apr 30, 2021 2:12pm
For the PGX equipment in Germany, the concept of modular design could imply capacity expansion by swapping out units as well as to scale up at mulitple sites or within the same site with additional lines. I'm a bit disappointed in the timeline for design (6 - 9  months) along with the installation, commissioning and upgrade of the plant facilities to which the equipment will be installed ...more  
Comment by archeo753 on Apr 30, 2021 3:18pm
Definitely could see near term income from yeast beta-glucan generated by the plant in Edmonton.  Also, think there are short term catalysts for share appreciation.  In May alone there is the presentation next week, Q1 results and possible update re: Covid theraputic Phase1/2.
Comment by stockfy on May 03, 2021 10:04am
Excellent said.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities